摘要
目的研究不同剂量阿托伐他汀钙片联合阿司匹林肠溶片治疗脑梗死患者的临床效果。方法选取于我院接受治疗的150例脑梗死患者为研究对象,按照患者就诊的先后顺序将其分为对照组(75例)与试验组(75例)。对照组患者实施10 mg阿托伐他汀联合阿司匹林肠溶片进行治疗,试验组患者实施20 mg阿托伐他汀联合阿司匹林肠溶片进行治疗。比较两组的治疗效果。结果试验组的治疗总有效率高于对照组(P<0.05);治疗后,两组患者的Barthel指数评分均升高,NIHSS评分均降低,且试验组优于对照组(P<0.05)。结论大剂量阿托伐他汀钙片联合阿司匹林肠溶片治疗脑梗死患者可提高其日常生活活动能力,改善神经功能缺损。
Objective To study the clinical effect of different doses atorvastatin calcium tablets combined with aspirin enteric-coated tablets on patients with cerebral infarction. Methods A total of 150 patients with cerebral infarction treated in our hospital were selected as the research objects. The patients were divided into control group(75 cases) and experimental group(75 cases) according to the order of patient’ visit to the doctor. The control group was treated with 10 mg atorvastatin combined with aspirin enteric-coated tablets, the experimental group was treated with 20 mg atorvastatin combined with aspirin enteric-coated tablets. The therapeutic effects of the two groups were compared. Results The total effective rate of treatment in the experimental group was higher than that in the control group(P<0.05);after treatment,Barthel index scores in both groups increased, and NIHSS scores decreased, and those in the experimental group were btter than the control group(P<0.05). Conclusion High dose atorvastatin calcium tablets combined with aspirin enteric-coated tablets in patients with cerebral infarction can improve the activity of daily living and the score of neurological deficit.
作者
黄振兴
HUANG Zhen-xing(Jiangdu People's Hospital of Yangzhou,Yangzhou 225200,China)
出处
《临床医学研究与实践》
2019年第34期57-58,共2页
Clinical Research and Practice
关键词
阿托伐他汀钙片
脑梗死
阿司匹林肠溶片
atorvastatin calcium tablet
cerebral infarction
aspirin enteric-coated tablet
